Table 2.
Characteristics of participants who completed the baseline assessment (n=24).a
| Characteristics | All participants who completed the baseline assessment (n=24), n (%) | Participants who completed the baseline the assessment and completed the welcome phase (n=14), n (%) | Participants who completed the baseline assessment but did not complete the welcome phase (n=10), n (%) | P value | ||
| Methamphetamine use disorder symptom severity | .70 | |||||
|
|
None (0-1 criteria) | 1 (4) | 0 (0) | 1 (10) |
|
|
|
|
Mild (2-3 criteria) | 2 (8) | 1 (7) | 1 (10) |
|
|
|
|
Moderate (4-5 criteria) | 0 (0) | 0 (0) | 0 (0) |
|
|
|
|
Severe (6-11 criteria) | 21 (88) | 13 (93) | 8 (80) |
|
|
| Routes of methamphetamine administration | ||||||
|
|
Smoked | 19 (79) | 10 (71) | 9 (90) | .36 | |
|
|
Injected | 12 (50) | 7 (50) | 5 (50) | >.99 | |
|
|
Orally ingested | 7 (29) | 4 (29) | 3 (30) | >.99 | |
|
|
Snorted | 9 (38) | 6 (43) | 3 (30) | .68 | |
|
|
Other | 2 (8) | 2 (14) | 0 (0) | .49 | |
| Other substances used in the past 30 days | ||||||
|
|
Alcohol | 10 (42) | 5 (36) | 5 (50) | .68 | |
|
|
Cannabis | 13 (54) | 7 (50) | 6 (60) | .70 | |
|
|
Cocaine | 4 (17) | 0 (0) | 4 (40) | .02 | |
|
|
Hallucinogens | 2 (8) | 0 (0) | 2 (20) | .16 | |
|
|
Heroin or other nonprescribed opioids | 11 (46) | 5 (36) | 6 (60) | .41 | |
|
|
Inhalants | 1 (4) | 0 (0) | 1 (10) | .42 | |
|
|
Ecstasy or molly | 3 (12) | 0 (0) | 3 (30) | .06 | |
|
|
PCPb | 2 (8) | 0 (0) | 2 (20) | .16 | |
|
|
Other synthetic drugs | 2 (8) | 1 (7) | 1 (10) | >.99 | |
|
|
Sedatives | 9 (38) | 4 (29) | 5 (50) | .40 | |
|
|
Other drugs | 1 (4) | 1 (7) | 0 (0) | >.99 | |
|
|
Any nonamphetamine drug listed above | 23 (96) | 13 (93) | 10 (100) | >.99 | |
|
|
Tobacco | 19 (79) | 11 (79) | 8 (80) | >.99 | |
| Benefits | ||||||
|
|
Medicaid | 22 (92) | 12 (86) | 10 (100) | .49 | |
|
|
Disability | 6 (25) | 4 (29) | 2 (20) | >.99 | |
|
|
Social security | 7 (29) | 3 (21) | 4 (40) | .39 | |
|
|
Welfare | 2 (8) | 2 (14) | 0 (0) | .49 | |
|
|
Supplemental Nutrition Assistance Program | 17 (71) | 9 (64) | 8 (80) | .65 | |
| Other baseline questionnaire measures | ||||||
|
|
Unhoused or in temporary or transitional housing | 5 (21) | 1 (7) | 4 (40) | .12 | |
|
|
Housing insecurityc | 12 (55) | 6 (46) | 6 (67) | .41 | |
|
|
Employedc | 5 (24) | 3 (25) | 2 (22) | >.99 | |
|
|
Lack of transportation | 10 (42) | 7 (50) | 3 (30) | .42 | |
|
|
Financial insecurityd | 15 (62) | 7 (50) | 8 (80) | .21 | |
|
|
Past-year jail or criminal justice system involvementc | 5 (22) | 3 (21) | 2 (22) | >.99 | |
aP values were obtained using Fisher exact tests and reflect differences between participants who completed the welcome phase and those who did not complete the welcome phase.
bPCP: phencyclidine.
cIn the subgroup of 14 participants who completed the welcome phase and the baseline survey, there was 1 (7%) participant who did not provide an answer about housing security and 2 (14%) who did not provide an answer to the question about employment. In the subgroup of 10 participants who did not complete the welcome phase but completed the baseline survey, there was 1 (10%) participant who did not provide an answer to the question about housing security, 1 (10%) who did not provide an answer to the question about employment, and 1 (10%) who did not provide an answer to the question about past-year jail or criminal justice system involvement.
dFinancial insecurity was defined as the self-reported inability to pay for at least 2 of the following things when needed in the previous year: food, clothing, utilities, childcare, medicine or health care, phone, or other.